Following his retirement as worldwide president of Johnson & Johnson Vision, Surgical, Tom Frinzi has joined CorneaGen’s board as its executive chair, according to a press release.
Frinzi has more than 40 years of experience in clinical-to-commercial transitions and has aided growth in a range of companies. Former chair William J. Link, PhD, will remain on the board.
“I have devoted my career to building companies that improve the vision — and lives — of people around the world,” Frinzi said in the release. “CorneaGen is a purpose-driven organization,
Uncategorized